维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Carrupt PA"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Molecular fields in quantitative structure-permeation relationships: the Vol-Surf approach显示文摘	CRUCIANI G CRIVORI P CARRUPT PA	2000	J Mol Struct (Theochem)2000，503，12：	1
2	The pH-partition profile of the anti-ischemic drug trimetazidine may explain its reduction of intracellular acidosis显示文摘	Reymond F Steyaert G Carrupt PA	1999	Pharm Res1999，16，5：	1
3	Molecular factors influencing retention on immobilized artificial membranes (IAM) compared to partitioning in liposomes and n-octanol 显示文摘	Taillardat-Bertschinger A Martinet CA Carrupt PA	2002	Pharm Res2002，19，6：	1
4	Molecular lipophilicity potential, a tool in 3D QSAR: method and applications显示文摘	Carrupt PA Testa B	1994	J Comput Aided Mol Des1994，8，2：	1
5	Structural damage to proteins caused by free radicals: assessment, protection by antioxidants and influence of protein binding 显示文摘	Salvi A Carrupt PA TiUemeng JP	2001	Biochem Pharmacol2001，61，10：	1
6	Structure-property relationships of trimetazidine derivatives and model compounds as potential antioxidants显示文摘	Ancerewicz J Migliavacca E Carrupt PA	1998	Free Radical Biology & Medicine1998，25，1：	1
7	Molecular properties and pharmacokinetis behavior of cetirizine,gwitterionic Ht-receptor antagonist显示文摘	Pagliara A Testa B Carrupt PA	1998	J Med Chen1998，41，6：	1
8	Parallel artificial membrane permeability assay : a new membrane for the fast prediction of passive human skin permeability 显示文摘	Ottaviani G Martel S Carrupt PA	2006	J Med Chem2006，49，13：	1
9	The PH partition profile of the anti-ischemic drug trunetazidine may explain its reduction of intracellular acidosis显示文摘	Revmond F Steyaert G Carrupt PA	1999	Pharm Res1999，16，3：	1
10	Molecular properties and pharmacokinetic behavior of cetirizine,a zwitterionic H 1 -receptor antagonist显示文摘	Pagliara A Testa B Carrupt PA	1998	J Med Chen1998，41，6：	1
11	The PH-partition profile of the anti-ischemic drug trimetazidine may explain its reduction of intracellular acidosis显示文摘	Reymond F Steyaert G Carrupt PA	1999	Pharm Res1999，16，：	1
12	The PH partition profile of the anti-ischemic drug trimetazidine may explain its reduction of intracellular acidosis显示文摘	Reymond F Steyaert G Carrupt PA	1999	Pharm Res1999，16，5：	1
13	The pH-partitionprofileoftheanti-ischemicdrug trimetazidine may explain its reduction of intracellular acidosis显示文摘	Reymond F Steyaert G Carrupt PA		0，，05：	1
14	Block of the hERG channel by bupivacaine: electrophysiological and modeling in- sights towards stereochemical optimization显示文摘	Sintra GL Carrupt PA Abriel H	2011	Eur J Med Chem2011，46，8：	1
15	Chiral inversion and hydrolysis of thalidomide: mechanisms and catalysis by bases and serum albumin, and chiral stability of teratogenic metabolites 显示文摘	Reist M Carrupt PA Francotte E	1998	Chem Res Toxicol1998，11，：	1
16	Molecular fields in quantitative structure-permeation relationships: the VolSurf approach显示文摘	Cruciani G Crivori P Carrupt PA	2000	J Mol Struct (Theochem)2000，503，12：	1
17	Evaluation and prediction of drug permeation显示文摘	Pagliara A Reist M Geinoz S Carrupt PA Testa B	1999	J Pharm Pharmacol1999，51，12：	1
18	MLP Tools : a PyMOL plugin for using the molecular lipophilicity potential in computer-aided drug design显示文摘	OBERHAUSER N NURISSO A CARRUPT PA	2014	Journal of Comput- er-Aided Molecular Design2014，28，5：	1
19	A simple model to predict blood-brain barrier permeation from 3D molecular fields显示文摘	Ooms F Weber P Carrupt PA Testa B	2002	Biochim Biophy Acta2002，1587，23：	1
20	Chiral inversion and hydrolysis of thalidomide: Mechanisms and catalysis by bases and serum albumin, and chiral stability of teratogenic metabolites 显示文摘	Reist M Carrupt PA Francotte E	1998	Chem Res Toxicol1998，11，12：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示